Literature DB >> 10366107

Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells.

G Tardif1, J P Pelletier, M Dupuis, C Geng, J M Cloutier, J Martel-Pelletier.   

Abstract

OBJECTIVE: We investigated the response of human osteoarthritic (OA) chondrocytes, in terms of collagenase 3 production, to growth factors and cytokines involved in the anabolism and catabolism of articular cartilage, and explored the major signaling pathways leading to its up-regulation.
METHODS: Human OA chondrocytes were treated with the following factors: the proinflammatory cytokine interleukin-1beta (IL-1beta), the growth factors basic fibroblast growth factor (bFGF), platelet-derived growth factor BB (PDGF-BB), parathyroid hormone (PTH), insulin-like growth factor 1 (IGF-1), transforming growth factor gamma1 (TGFbeta1), and TGFbeta2, the protein kinase (PK) activator antagonists for PKC, PKA, and PKG pathways, and phospholipase A2 and tyrosine kinases, as well as the antiinflammatory cytokines IL-4, IL-10, and IL-13. Collagenase 3 expression and synthesis were determined. Comparison was made with collagenase 1.
RESULTS: The human OA chondrocyte population could be divided into 2 categories: the L chondrocytes, showing low collagenase 3 basal synthesis levels and high sensitivity to IL-1beta stimulation; and the H chondrocytes, high collagenase 3 basal synthesis levels and low IL-1beta inducibility. In L chondrocytes, all growth factors stimulated collagenase 3 production. In H chondrocytes, PTH, IGF-1, and TGFbeta had little or no impact; bFGF slightly stimulated it and PDGF-BB showed the same pattern as in the L chondrocytes. The effects of all growth factors, except TGFbeta, on collagenase 1 synthesis followed those of collagenase 3, albeit to a higher degree. Interestingly and unlike collagenase 3, the effects of TGFbeta on collagenase 1 could not be related to the state of the cells, but rather, depended on the isoform. Indeed, TGFbeta2 did not induce collagenase 1 synthesis, whereas TGFbeta1 stimulated it. Among the PK activators tested, phorbol myristate acetate was the strongest inducer, suggesting a major involvement of the PKC pathway. IL-13 inhibited collagenase 3 production, IL-4 had little effect, and IL-10 had none.
CONCLUSION: This study shows that collagenase 3 production in human OA chondrocytes depends on the physiologic state of the cell. TGFbeta might be responsible for the change in cells from the L to the H state. Importantly, our in vitro data implicate TGFbeta2 as a possible in vivo agent capable of specifically triggering collagenase 3 production over that of collagenase 1 in OA cartilage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366107     DOI: 10.1002/1529-0131(199906)42:6<1147::AID-ANR11>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Protein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3- and ERK-dependent c-fos induction.

Authors:  Gary J Litherland; Martina S Elias; Wang Hui; Christopher D Macdonald; Jonathon B Catterall; Matt J Barter; Matthew J Farren; Matthew Jefferson; Andrew D Rowan
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

2.  Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production.

Authors:  Elena V Tchetina; John Antoniou; Michael Tanzer; David J Zukor; A Robin Poole
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

3.  The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway.

Authors:  C Boileau; J-P Pelletier; G Tardif; H Fahmi; S Laufer; M Lavigne; J Martel-Pelletier
Journal:  Ann Rheum Dis       Date:  2004-10-21       Impact factor: 19.103

4.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

5.  Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis.

Authors:  Carol G Chen; Daniel Thuillier; Emily N Chin; Tamara Alliston
Journal:  Arthritis Rheum       Date:  2012-10

6.  Decreased expression of interleukin 13 in human lung emphysema.

Authors:  A Boutten; M Bonay; S Laribe; G Leseche; Y Castier; V Leçon-Malas; M Fournier; G Durand; M Aubier; M Dehoux; B Crestani
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

7.  Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction.

Authors:  Mei Zhu; Mo Chen; Michael Zuscik; Qiuqian Wu; Yong-Jun Wang; Randy N Rosier; Regis J O'Keefe; Di Chen
Journal:  Arthritis Rheum       Date:  2008-07

8.  Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes.

Authors:  Xibin Wang; Yingjie Song; Jennifer L Jacobi; Rocky S Tuan
Journal:  Growth Factors       Date:  2009-02       Impact factor: 2.511

9.  Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids.

Authors:  T Ushiyama; T Chano; K Inoue; Y Matsusue
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

10.  Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes.

Authors:  Ginette Tardif; David Hum; Jean-Pierre Pelletier; Nicolas Duval; Johanne Martel-Pelletier
Journal:  BMC Musculoskelet Disord       Date:  2009-11-30       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.